<DOC>
	<DOCNO>NCT00772356</DOCNO>
	<brief_summary>This crossover , glucose-clamp study investigate impact different basal insulin infusion rate glucose control employ insulin pump different insulin delivery regimen . Patients randomize one 2 group , receive first study day insulin via pump pulsatile quasi-continuous delivery mode . On second study day switch treatment alternative delivery regimen . The anticipated duration trial 2 study day target sample size 14 individual .</brief_summary>
	<brief_title>A Monocenter , Open-Label Glucose Clamp Study Examining Metabolic Effect Insulin Infusion Intervals Basal Insulin Infusion Patients With Type I Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Male patient 1865 year age Type I diabetes mellitus Currently continuous subcutaneous insulin infusion therapy Proliferative retinopathy maculopathy require actue treatment within last 6 month Use systemic corticoid last 3 month Treatment medication know interfere glucose metabolism</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2010</verification_date>
</DOC>